Qualitest Recalls Perphenazine Tablets Due to Cracked Coating
Vintage Pharmaceuticals is recalling 2,755 bottles of Perphenazine 8 mg tablets due to a possibility of cracked or split tablet coatings.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, and the source text describes a physical defect (cracked coating) without reporting any illnesses or injuries, fitting the criteria for a moderate severity recall.
Plain-English summary
Vintage Pharmaceuticals LLC DBA Qualitest Pharmaceuticals is recalling 2,755 bottles of Perphenazine Tablets, USP, 8 mg. The recall involves NDC 0603-5092-21, Lot C1130511A, with an expiration date of 5/13. The product was distributed nationwide and in Puerto Rico.
The recall was initiated because of a possibility of cracked or split coating on the tablets. This is a Class II recall, indicating that the use of, or exposure to, the violative product may cause temporary or medically reversible adverse health consequences.
Consumers who have this product should stop using it and contact their pharmacist or the recalling firm for instructions on how to return the product for a refund.
The recalled product
- Product
- Perphenazine Tablets, USP, 8 mg, 100-count tablets per bottle, Manufactured for: Qualitest Pharmaceuticals, Huntsville, AL 35811, NDC 0603-5092-21.
- Category
- Drug — Tablets
- Hazard
- Affected units
- 2,755
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot C1130511A
- Exp 5/13
Distribution
Related recalls
Same manufacturer · Vintage Pharmaceuticals LLC DBA Qualitest Pharmaceuticals
See all →- LowQualitest Recalls Hydrocortisone Lotion for Excessive Potency
FDA (Drugs) · 2017-05-31
- LowQualitest Recalls Dexamethasone Elixir Due to Failed Impurity Specifications
FDA (Drugs) · 2017-02-01
- LowQualitest Recalls Temazepam Capsules Due to Failed Stability Specifications
FDA (Drugs) · 2017-01-11
- ModerateQualitest Recalls Hydrochlorothiazide Capsules Due to Particulate Matter
FDA (Drugs) · 2015-11-25
- LowQualitest Recalls Ranitidine Syrup Due to Preservative Stability Failure
FDA (Drugs) · 2015-11-11
Same hazard · physical defect
See all →- HighThermodilution Catheter May Bend During Use, Causing Monitor Errors
FDA (Devices) · 2023-04-19
- ModerateBard Clean-Cath Intermittent Catheter Recalled for Packaging and Tip Defects
FDA (Devices) · 2021-04-28
- HighFerring Recalls ZOMA-Jet 5 Demonstration Kits Due to Defective Delivery System
FDA (Drugs) · 2021-04-07
- HighROi CPS Recalls Custom Procedure Packs with Flaking Gauze Sponges
FDA (Devices) · 2021-01-06
- HighGE Healthcare Recalls Flow Sensor Service Parts with Damaged Tubes
FDA (Devices) · 2020-11-11